Category Archives: Top Market News

Northland Securities Remains a Buy on Cryolife (CRY)

In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Cryolife (CRY – Research Report), with a price target of $32. The company’s shares opened today at $28.35. Kalia wrote: “We continue to be strongly

Analysts Are Bullish on These Healthcare Stocks: Viveve Medical Inc (VIVE), Epizyme (EPZM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viveve Medical Inc (VIVE – Research Report) and Epizyme (EPZM – Research Report) with bullish sentiments. Viveve Medical Inc (VIVE) In a

Paratek Pharmaceuticals (PRTK) Received its Third Buy in a Row

After Canaccord Genuity and Cantor Fitzgerald gave Paratek Pharmaceuticals (NASDAQ: PRTK) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Ed Arce maintained a Buy rating on Paratek Pharmaceuticals today and set a

Analysts’ Top Healthcare Picks: Aeterna Zentaris (AEZS), Amarin (AMRN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aeterna Zentaris (AEZS – Research Report) and Amarin (AMRN – Research Report) with bullish sentiments. Aeterna Zentaris (AEZS) In a report released

F5 Networks (FFIV) Receives a Buy from Credit Suisse

In a report released yesterday, Sami Badri from Credit Suisse maintained a Buy rating on F5 Networks (FFIV – Research Report), with a price target of $218. The company’s shares closed yesterday at $161.86. According to TipRanks.com, Badri is currently

IBM (IBM) Gets a Hold Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph Foresi maintained a Hold rating on IBM (IBM – Research Report) today and set a price target of $140. The company’s shares opened today at $121.62. Foresi noted: “: We maintain our Neutral rating on IBM